MedTrace Logo

Genetic Counseling in Women at Risk for BRCA1 or BRCA2 Mutations

NCT00416754 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1109

Last updated 2017-04-07

No results posted yet for this study

Summary

RATIONALE: Genetic counseling and using an interactive computer program may help women at risk for breast cancer make medical decisions about treatment.

PURPOSE: This randomized clinical trial is studying standard genetic counseling to see how well it works when given together with or without a medical decision-making computer program in women at risk for BRCA1 or BRCA2 mutations.

Conditions

Interventions

OTHER

counseling intervention

subjects will receive genetic counseling

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Georgetown University

    lead OTHER

Principal Investigators

  • Marc Schwartz, PhD · Lombardi Comprehensive Cancer Center

Study Design

Allocation
RANDOMIZED
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
25 Years
Max Age
75 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-12-31
Primary Completion
2006-12-31
Completion
2006-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00416754 on ClinicalTrials.gov